191108_Appendix 3B - Exercise of Options Categories: Financial Reports 2019, News & Announcements 2019By PharmAust08/11/2019Related posts31 December, Top 20 Shareholders31/12/2019Expanded Site Recruitment for Monepantel Phase II Trial in Pet Dogs with Cancer11/12/201929 November, Top 20 Shareholders02/12/2019Pitt Street Research Life Science Conference: Investor Presentation28/11/2019Appendix 3B, Exercise of Options19/11/2019Progress in Recruitment for Phase II Trial in Dogs04/11/2019
